Showing results (741-750 of 1,038) with videos related to

Sort By:
Pageof 104
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Measuring tumor response and shape change on CT: esophageal cancer as a paradigmL H Schwartz, J A C Colville, M S Ginsberg, et al.
Ecology and Evolution|July 14, 2025
Environmental DNA Detects Endangered Texas Hornshell and Its HostsDaniel H Mason, Heidi A Henderson, Thomas W Franklin, et al.
Molecular Therapy. Methods & Clinical Development|September 25, 2023
In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humansMaura K Schwartz, Shibi Likhite, Tatyana A Vetter, et al.
Ecology and Evolution|March 14, 2018
Repurposing environmental DNA samples-detecting the western pearlshell (Margaritifera falcata) as a proof of conceptJoseph C Dysthe, Torrey Rodgers, Thomas W Franklin, et al.
Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.
British Journal of Cancer|May 26, 2011
Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)G K Schwartz, P M LoRusso, M A Dickson, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Diagnostic value of a two-dimensional echocardiographic score for left ventricular hypertrophy validated by the Imatron CT scan in familial hypertrophic cardiomyopathy]J F Forissier, P Charron, S Tézenas du Montcel, et al.
Journal of the American College of Cardiology|May 1, 1987
Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative studyJ J Mercadier, D de la Bastie, P Ménasché, et al.
Human Genetics|April 1, 1997
The role of immunocytochemistry and linkage analysis in the prenatal diagnosis of merosin-deficient congenital muscular dystrophyI Naom, M D'Alessandro, C Sewry, et al.
Investigational New Drugs|June 5, 2012
Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumorsGary K Schwartz, Richard D Carvajal, Rachel Midgley, et al.
Pageof 104